Centre for immunobiology and immunotherapy

Major programs

  • Objectives under each program:

    1.Understanding effector and regulatory T cell response in autoimmune, inflammatory diseases and cancer.

    2.Targeting host-factors for novel anti-viral and anti-bacterial therapy

    3.Understanding the Th9 and Th17 cells in immunity and autoimmunity.

    4.Novel small molecule based checkpoint inhibitors (PD1-PDL-1) for cancer immunotherapy

    5.Establishment of advanced pre-clinical models to understand disease pathophysiology.

    6.Immunobiology of Influenza, SARS-CoV-2 and emerging viral infections.

 

 

Name of faculty members and Scientists

DR. AMIT AWASTHI, SENIOR PROFESSOR
DR. ZAIGHAM ABBAS RIZVI, PRINCIPAL SCIENTIST-I
DR. DEEPAK KUMAR RATHORE, SENIOR RESEARCH SCIENTIST
DR. RAMESH CHANDRA RAI, SCIENTIST D
DR. TANVI AGRAWAL, RESEARCH SCIENTIST
DR. SRIKANTH SADHU, RESEARCH SCIENTIST
DR. HARSHIT SINGH, RESEARCH SCIENTIST
DR. RAJDEEP DALAL, PROJECT RESEARCH SCIENTIST-III

The centre/facility is open to providing services to academia and industry. For any queries, contact the following

Contact Details

Dr. Amit Awasthi
 aawasthi@thsti.res.in
 0129- 2876482